I have been conferred four honorary doctorate degrees - doctor medicinae honoris causa from Aalborg University, Denmark (http://bit.ly/2fGyIfC); University of Medicine & Pharmacy “Carol Davila”, Bucharest, Romania (http://bit.ly/2CVadVP) ; Belgrade University, Serbia; and i'Universite de Tours, France (http://bit.ly/2I3VyeH).
Chairman of the Writing Group of the 2018 American College of Chest Physicians (ACCP Guidelines on Antithrombotic therapy for AF (10th edition). For the 9th ACCP guideline (2012), I was appointed as ‘content expert’ (ie. ’deputy editor’) for the AF guideline chapter.
European Society of Cardiology and European Heart Rhythm Association (EHRA): Chairman (2011-2015; and still remain on Executive Steering Committee, as ‘Past Chairman’ 2016-) of the European Society of Cardiology (ESC) EuroObservational Research Programme on Atrial Fibrillation (EORP-AF), defining the epidemiology and management of AF in Europe. I have also managed and developed international registry collaborations with ESC/non-ESC countries (Asia-Pacific HRS, Japan, China, Serbia, Iran) as part of the INTER-AF collaboration (see PMID: 27806965). I am a member of the INTER-AF steering committee, which is an American College of Cardiology-led collaboration of academics developing AF registry dataset harmonisation and inter-regional comparisons.
Since 2012, I have chaired 6 ESC/European Heart Rhythm Association (EHRA) consensus guidelines eg. Arrhythmias in AF with Heart failure (2015); AF with Acute coronary syndrome/Stenting (2014); valvular AF, hypertension (2016-2017).
Member, ESC Clinical Practice Guideline Committee (2014-2016); my work included implementation recommendations, self-testing modules & assessment of quality/audit standards. Peer reviewer of 8 ESC guidelines since 2012. Review Coordinator, 2015 ESC ventricular arrhythmia guidelines.
2015-2017, EHRA Board member/Chair, Scientific Documents Committee, coordinated new guideline development/reviews & facilitated implementation/education. From 2017-2018, I was appointed to the EHRA Governing Board as ‘Research Pillar’ Chair, responsible for scientific initiatives/innovation and scientific documents. In 2014-2015, Chaired group developing EHRA AF patient education website (afibmatters.org) & translation into multilanguages.
National Institute for Health and Care Excellence (NICE): External expert and co-author for the NICE AF Quality Standards (2015): helped defined standards/benchmarking & co-author (2015). I am an Expert Adviser for NICE Centre for Clinical Practice (including NICE Medicines & Prescribing Centre; 2016-). I was the clinical expert to NICE, also representing the British Cardiovascular Society, on its evaluation of dabigatran (2011) and apixaban (2013) for stroke prevention in AF (2011). I was on the Guideline Development Group for the latest UK NICE guidelines on atrial fibrillation (2014), and part of the NICE Guideline surveillence review for AF (2016-2017).
Appointed to SIGN (Scottish Intercollegiate Guidelines Network, 2016-) producing healthcare guidelines/service standards for NHS Scotland.
National Institute for Health Research (NIHR): Currently member of NIHR College of Senior Investigators (2017-).
Data safety management board (DSMB member for Canadian Institutes for Health Research (CIHR) funded trials – BRUISE/BRUISE2 (2009-2017).
External expert reviewer, 2016 Taiwan Society of Cardiology and Taiwan Heart Rhythm Society joint guidelines on AF management; 2017 Asia-Pacific Heart Rhythm Society AF guidelines (2017); 2018 American College of Cardiology/American Heart Association/Heart Rhythm Society Focused Update Guidelines on the Management of AF; 2018 Korean Heart Rhythm Society guidelines on AF management.
Member of Council, Royal College of Physicians of Edinburgh (2015-)